Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Impact Biosystems was a Boston-based private health technology company that developed connected hardware and software for athlete recovery, muscle monitoring, and performance optimization. Its best-known products were marketed under the Pact brand, including a connected massager and the Pact Sense muscle scanner, which aimed to personalize recovery and provide data-driven insights on muscle health. The company positioned itself at the intersection of medical device, wellness, and digital health, serving athletes and active consumers rather than operating as a traditional therapeutics biotech. Public startup databases and company-profile sources indicate that it raised seed financing and remained private, but more recent directory data classify the company as closed. Based on the available evidence, Impact Biosystems should be treated as a health-tech/device company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Impact Biosystems.